$GALT
Galectin Therapeutics Inc.
XNAS
Why is GALT down today? It is at $4.02 (-2.90%), and our scanner flagged it 16 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment GALT spikes, and full due diligence on GALT — key stats, earnings, dilution and insider activity. Free.
Get free $GALT alerts the moment volume spikes
Our scanner flagged $GALT 16 times in the last 30 days. Create a free account to track $GALT, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $4.02
- Change today
- -2.90%
- Previous close
- $4.14
- 52-week range
- $2.02 – $7.13
- Market cap
- $405M
- Institutional own.
- 18.05%
- Total held
- 75.3%
- Tradeable float
- 24.9M 25% of shares · after 57% insiders + 18% institutions
- Short interest
- 9.0M ▲ +4% vs prior · as of 2026-08-14
- Short % of float
- 36.1%
- Days to cover
- 21.6d
- Avg daily volume
- 458K
- Exchange
- XNAS
- 5m
- 1.3x
- 15m
- 1.3x
- 1h
- 1.1x
- 1D
- --
Get free GALT + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $GALT down today?
Here is the latest on GALT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for GALT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystGalectin Therapeutics Reports June 30, 2026 Financial Results and Provides Business UpdateReported Finally, the recent issuance of common stock converting approximately $105.8 million in debt and accrued interest from our chairman, Mr. Uihlein, significantly enhanced ourReported Elimination of approximately $105.8 million in total debt, consisting of $91.0 million in principal and $14.8 million in accrued interestReported As of June 30, 2026, the Company had $13.2 million of cash and cash equivalents. Additionally, the Company has $10 million remaining available under a line of credit provided by its Chairman of the, from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Insiders
Insiders selling0 buys, 6 sells last 3 months (5/45 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Uihlein Richard E Director | Other | 34.38M 34.1% of company | added 100% | 44.74M | $103.1M at $3.00 | Jul 31, 26 |
Jamil Khurram Officer | Sold (automatic/other) | -16K 0.02% of company | n/a | n/a | $83K at $5.13 | Jul 14, 26 |
Jamil Khurram Officer | Other | 16K 0.02% of company | n/a | 16K | $49K at $3.04 | Jul 14, 26 |
Jamil Khurram Officer | Sold (automatic/other) | -47K 0.05% of company | n/a | n/a | $239K at $5.04 | Jun 29, 26 |
Jamil Khurram Officer | Other | 47K 0.05% of company | n/a | 47K | $119K at $2.50 | Jun 29, 26 |
Shlevin Harold H. Director | Sold (automatic/other) | -22K 0.02% of company | sold 77% | 7K | $112K at $5.04 | Jun 29, 26 |
Shlevin Harold H. Director | Other | 22K 0.02% of company | added 100% | 29K | $27K at $1.23 | Jun 29, 26 |
Jamil Khurram Officer | Sold (automatic/other) | -5K | n/a | n/a | $23K at $5.00 | Jun 26, 26 |
Jamil Khurram Officer | Other | 5K | n/a | 3K | $10K at $2.20 | Jun 26, 26 |
Shlevin Harold H. Director | Sold (automatic/other) | -8K | sold 54% | 7K | $39K at $5.00 | Jun 26, 26 |
Shlevin Harold H. Director | Other | 8K | added 100% | 14K | $10K at $1.23 | Jun 26, 26 |
Jamil Khurram Officer | Sold (automatic/other) | -8K | n/a | n/a | $24K at $3.14 | Jun 23, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Active shelfActive shelf on file — the company can issue new shares on demand (valid ~3 years). If $GALT runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- At-the-market (ATM) program — sells new shares into the market gradually over time · About $200.0M in size
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$GALT Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$GALT Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
GALT stock FAQ
Why is $GALT down today?
Here is the latest on GALT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for GALT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the GALT stock price today?
GALT last traded at $4.02, down 2.90% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live GALT alerts?
The GALT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged GALT 16 times in the last 30 days.
What exchange is GALT on?
GALT (Galectin Therapeutics Inc.) trades on XNAS, with a market cap of about $405M.
Is GALT good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge GALT for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.